FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Nicolaus Kröger

Research Profile

Procedures

Disorders

Concepts & Ideas

Phenomena

Recurrence

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Lisa Billecke; Carsten Bokemeyer; Judith Dierlamm; Monika Engelhardt; Eray Goekkurt; Hans-Heinrich Heidtmann; Nicolaus Kröger; Merav Leiba; Andreas Marx; Jakob Matschke; Annette M May; Eva M Murga Penas; Arnon Nagler; Ginette Schiby; Markus Tiemann; Eik Vettorazzi; Jozef Zustin; Georgia Schilling
Cytogenetics of extramedullary manifestations in multiple myeloma.
Anthony Oyekunle; Philippe Schafhausen; Thomas Stübig; Christine Wolschke; Tatjana Zabelina; Axel R Zander; Haefaa Alchalby; Francis Ayuk; Ulrike Bacher; Mascha Binder; Maximilian Christopeit; Heinrich Lellek; Ingo Müller; Nicolaus Kröger
Outcome of allogeneic SCT in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy.
Nicolaus Kröger; Georgia Schilling; Sabine Schwarz; Thomas Stübig; Christine Wolschke; Tatjana Zabelina; Silke Zeschke; Haefaa Alchalby; Djordje Atanackovic; Francis Ayuk; Ulrike Bacher; A Badbaran; Boris Fehse; Timon Hansen; Marion Heinzelmann; Evgeny Klyuchnikov; Axel R Zander
Impact of high-risk cytogenetics and achievement of molecular remission on long-term freedom from disease after autologous-allogeneic tandem transplantation in patients with multiple myeloma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Nicolaus Kröger (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Lisa Billecke; Carsten Bokemeyer; Judith Dierlamm; Monika Engelhardt; Eray Goekkurt; Hans-Heinrich Heidtmann; Nicolaus Kröger; Merav Leiba; Andreas Marx; Jakob Matschke; Annette M May; Eva M Murga Penas; Arnon Nagler; Ginette Schiby; Markus Tiemann; Eik Vettorazzi; Jozef Zustin; Georgia Schilling
Cytogenetics of extramedullary manifestations in multiple myeloma.
British journal of haematology 2013;161(1):87-94.
2013: Anthony Oyekunle; Philippe Schafhausen; Thomas Stübig; Christine Wolschke; Tatjana Zabelina; Axel R Zander; Haefaa Alchalby; Francis Ayuk; Ulrike Bacher; Mascha Binder; Maximilian Christopeit; Heinrich Lellek; Ingo Müller; Nicolaus Kröger
Outcome of allogeneic SCT in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy.
Annals of hematology 2013;92(4):487-96.
2013: Nicolaus Kröger; Georgia Schilling; Sabine Schwarz; Thomas Stübig; Christine Wolschke; Tatjana Zabelina; Silke Zeschke; Haefaa Alchalby; Djordje Atanackovic; Francis Ayuk; Ulrike Bacher; A Badbaran; Boris Fehse; Timon Hansen; Marion Heinzelmann; Evgeny Klyuchnikov; Axel R Zander
Impact of high-risk cytogenetics and achievement of molecular remission on long-term freedom from disease after autologous-allogeneic tandem transplantation in patients with multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(3):398-404.
2013: Maximilian Christopeit; T Haferlach; Evgeny Klyuchnikov; Nicolaus Kröger; K Miersch; S Ocheni; Philippe Schafhausen; Tatjana Zabelina; A R Zander; Francis Ayuk; M Binder; C Bokemeyer; Anthony Oyekunle
Evaluation of BM cytomorphology after allo-SCT in patients with MDS.
Bone marrow transplantation 2013;48(3):465-6.
2013: Nicolaus Kröger; M Kropff; K-H Pflüger; Georgia Schilling; T Stübig; Christine Wolschke; Tatjana Zabelina; Djordje Atanackovic; Francis Ayuk; Anthony Oyekunle; A Badbaran; A Burchert; T Hansen; Y Hildebrandt; Evgeny Klyuchnikov; Axel R Zander
Toxicity-reduced, myeloablative allograft followed by lenalidomide maintenance as salvage therapy for refractory/relapsed myeloma patients.
Bone marrow transplantation 2013;48(3):403-7.
2013: Nicolaus Kröger; V Leblond; N Milpied; Mohamad Mohty; M Robin; N Schaap; Anja van Biezen; L Volin; Tatjana Zabelina; H Alchalby; J Berger; D Blaise; Theo de Witte; L de Wreede; J Finke
Allogeneic stem cell transplantation for older advanced MDS patients: improved survival with young unrelated donor in comparison with HLA-identical siblings.
Leukemia 2013;27(3):604-9.
2013: Christine Wolschke; Axel Zander; Stefan Schönland; Thomas Stübig; Djordje Atanackovic; Francis Ayuk; Peter Dreger; Ute Hegenbart; Marion Heinzelmann; York Hildebrandt; Nicolaus Kröger
Postallograft lenalidomide induces strong NK cell-mediated antimyeloma activity and risk for T cell-mediated GvHD: Results from a phase I/II dose-finding study.
Experimental hematology 2013;41(2):134-142.e3.
2013: Thorsten Derlin; Christian R Habermann; Jochen Herrmann; Nicolaus Kröger; Silvia Münster; Kersten Peldschus; Thomas Stübig; Gerhard Adam; Peter Bannas; Christoph Weber
Comparative diagnostic performance of ¹⁸F-FDG PET/CT versus whole-body MRI for determination of remission status in multiple myeloma after stem cell transplantation.
European radiology 2013;23(2):570-8.
2012: M Christopeit; T Haferlach; Evgeny Klyuchnikov; Nicolaus Kröger; K Miersch; Philippe Schafhausen; T Zabelina; A R Zander; Francis Ayuk; M Binder; C Bokemeyer; Ulrike Bacher
Evaluation of BM cytomorphology after allo-SCT in patients with AML.
Bone marrow transplantation 2012;47(12):1538-44.
2012: Evgeny Klyuchnikov; Guido Kobbe; Christian Könecke; Arnon Nagler; Avichai Shimoni; Christine Wolschke; Axel R Zander; Ulrike Bacher; Martin Bornhäuser; Ernst Holler; Nicolaus Kröger
Donor lymphocyte infusions and second transplantation as salvage treatment for relapsed myelofibrosis after reduced-intensity allografting.
British journal of haematology 2012;159(2):172-81.
2012: Peter Bannas; Thorsten A Bley; Thorsten Derlin; Christine Eulenburg; Hannah B Hentschel; Nicolaus Kröger; Thomas Stübig; András Treszl; Gerhard Adam; Jin Yamamura; Christoph Weber
Diagnostic performance of whole-body MRI for the detection of persistent or relapsing disease in multiple myeloma after stem cell transplantation.
European radiology 2012;22(9):2007-12.
2012: Kai Hübel; O Jaksic; Z Koristek; Nicolaus Kröger; F Lanza; R M Lemoli; G Mikala; M Mohty; D Selleslag; N Worel; J F Apperley; Grzegorz Basak; K W Douglas; M M Fresen; I H Gabriel; C Geraldes; R F Duarte
European data on stem cell mobilization with plerixafor in non-Hodgkin's lymphoma, Hodgkin's lymphoma and multiple myeloma patients. A subgroup analysis of the European Consortium of stem cell mobilization.
Bone marrow transplantation 2012;47(8):1046-50.
2012: Djordje Atanackovic; Katrin Bartels; Carsten Bokemeyer; Yanran Cao; York Hildebrandt; Christiane Keller; Nesrine Lajmi; Andreas H Marx; Sabrina Meyer; Jens Panse; Henrike Reinhard; Orhan Sezer; Julia Templin; Ria Uhlig; Axel R Zander; Jozef Zustin; Nicolaus Kröger
Role of interleukin 16 in multiple myeloma.
Journal of the National Cancer Institute 2012;104(13):1005-20.
2012: Nicolaus Kröger
Allogeneic stem cell transplantation for elderly patients with myelodysplastic syndrome.
Blood 2012;119(24):5632-9.
2012: Lisa Billecke; Carsten Bokemeyer; Monika Engelhardt; Eray Goekkurt; Nicolaus Kröger; Merav Leiba; Andreas Marx; Jakob Matschke; Annette M May; Arnon Nagler; Eva Maria Murga Penas; Ginette Schiby; Markus Tiemann; Jozef Zustin; Georgia Schilling
Similar incidences of TP53 deletions in extramedullary organ infiltrations, soft tissue and osteolyses of patients with multiple myeloma.
Anticancer research 2012;32(5):2031-4.
2012: Haefaa Alchalby; Francis Ayuk; Ulrike Bacher; Wolfgang Bethge; Martin Bornhäuser; Guntram Büsche; Ernst Holler; Guido Kobbe; Hans Michael Kvasnicka; Rainer Schwerdtfeger; Dinah-Rohina Yunus; Tatjana Zabelina; Axel R Zander; Nicolaus Kröger
Risk models predicting survival after reduced-intensity transplantation for myelofibrosis.
British journal of haematology 2012;157(1):75-85.
2012: Thorsten Derlin; Christian R Habermann; Jochen Herrmann; Susanne Klutmann; Christoph Weber; Christian Wisotzki; Christine Wolschke; Francis Ayuk; Nicolaus Kröger
18F-FDG PET/CT for detection and localization of residual or recurrent disease in patients with multiple myeloma after stem cell transplantation.
European journal of nuclear medicine and molecular imaging 2012;39(3):493-500.
2012: Nicolaus Kröger; Mohamad Mohty; Arnon Nagler; Qing Yi
Immunotherapy for multiple myeloma.
Clinical & developmental immunology 2012;2012():797165.
2012: Silke Heidenreich; York Hildebrandt; A Badbaran; Thomas M C Binder; Thomas H Eiermann; Heidi Sierich; Thomas Stübig; Christine Zu Eulenburg; Nicolaus Kröger
Impact of the NK cell receptor LIR-1 (ILT-2/CD85j/LILRB1) on cytotoxicity against multiple myeloma.
Clinical & developmental immunology 2012;2012():652130.
2012: Sebastian Kobold; Nicolaus Kröger; Nesrine Lajmi; Tim Luetkens; Henrike Reinhard; Orhan Sezer; Julia Templin; Britta Marlen Bartels; Katrin Bartels; Carsten Bokemeyer; Yanran Cao; Friedrich Haag; York Hildebrandt; Djordje Atanackovic
Longitudinal analysis of tetanus- and influenza-specific IgG antibodies in myeloma patients.
Clinical & developmental immunology 2012;2012():134081.
2011: Claudia Langebrake; Michael Baehr; Friederike Bernhardt; Nicolaus Kröger; Axel R Zander
Drug dosing and monitoring in obese patients undergoing allogenic stem cell transplantation.
International journal of clinical pharmacy 2011;33(6):918-24.
2011: Heidi Duske; Nicolaus Kröger; Sonja Schrepfer; Andreas Sputtek; Thomas Binder; Thomas Eiermann
Assessment of physiologic natural killer cell cytotoxicity in vitro.
Human immunology 2011;72(11):1007-12.
2011: Djordje Atanackovic; Katrin Bartels; Carsten Bokemeyer; Yanran Cao; Gregor Fuchs; Susanna Hegewisch-Becker; York Hildebrandt; Benjamin Kloth; Guido Kobbe; Nesrine Lajmi; Tim Luetkens; Sabrina Meyer; Uwe Platzbecker; Henrike Reinhard; Georgia Schilling; Thomas Schroeder; Nicolaus Kröger
Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemia.
American journal of hematology 2011;86(11):918-22.
2011: Nicolaus Kröger; T Stübig; Tatjana Zabelina; A R Zander; Y Hilde-brandt; Evgeny Klyuchnikov; H Alchalby; Djordje Atanackovic; Francis Ayuk; U Bacher; J Berger; T Binder; H Duske; Thomas Eiermann
Donor KIR haplotype B improves progression-free and overall survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma.
Leukemia 2011;25(10):1657-61.
2011: Djordje Atanackovic; Katrin Bartels; Carsten Bokemeyer; Yanran Cao; York Hildebrandt; Adam Jadczak; Sebastian Kobold; Nesrine Lajmi; Andreas H Marx; Sabrina Meyer; Jens Panse; Henrike Reinhard; Julia Templin; Axel R Zander; Nicolaus Kröger
Surface molecule CD229 as a novel target for the diagnosis and treatment of multiple myeloma.
Haematologica 2011;96(10):1512-20.
2011: Ulrike Bacher; Torsten Haferlach; Hans Kreipe; Susanne Schnittger; Nicolaus Kröger
Recent advances in diagnosis, molecular pathology and therapy of chronic myelomonocytic leukaemia.
British journal of haematology 2011;153(2):149-67.
2011: Andreas Sputtek; Michael V Lioznov; Nicolaus Kröger; Arthur W Rowe
Bioequivalence comparison of a new freezing bag (CryoMACS(®)) with the Cryocyte(®) freezing bag for cryogenic storage of human hematopoietic progenitor cells.
Cytotherapy 2011;13(4):481-9.
2011: Nicolaus Kröger
Approaches to relapse after allogeneic stem cell transplantation.
Current opinion in oncology 2011;23(2):203-8.
2011: Evgeny Klyuchnikov; Andreas Sputtek; Olga Slesarchuk; Michael V Lioznov; Thomas Stübig; Ulrike Bacher; Gitta Amtsfeld; Edeltraut Merle; Marie-Luise Reckhaus; Boris Fehse; Christine Wolschke; Raissa Adjallé; Francis Ayuk; Axel Zander; Nicolaus Kröger
Purification of CD4+ T cells for adoptive immunotherapy after allogeneic hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(3):374-83.
2011: Nicolaus Kröger; Tatjana Zabelina; Anja van Biezen; Ronald Brand; Dietger Niederwieser; Rodrigo Martino; Zi Yi Lim; Francesco Onida; Christoph Schmid; Laurent Garderet; Marie Robin; Michael van Gelder; Reinhard Marks; Argiris Symeonidis; Guido Kobbe; Theo de Witte
Allogeneic stem cell transplantation for myelodysplastic syndromes with bone marrow fibrosis.
Haematologica 2011;96(2):291-7.
2011: Anthony Oyekunle; Axel R Zander; Michele Baccarani; Evgeny Klyuchnikov; Nicolaus Kröger; S Ocheni; Ulrike Bacher
Challenges for allogeneic hematopoietic stem cell transplantation in chronic myeloid leukemia in the era of tyrosine kinase inhibitors.
Acta haematologica 2011;126(1):30-9.
2011: S Ocheni; Anthony Oyekunle; Nicolaus Kröger; Francis Ayuk; Evgeny Klyuchnikov; Soenke Arps; Karsten Held; Tatjana Zabelina; Raissa Adjallé; Christine Wolschke; Axel Rolf Zander; Anthony Oyekunle
Second allogeneic stem cell transplantation in a patient with hypoplastic myelodysplastic syndrome following a primary diagnosis of aplastic anaemia.
Acta haematologica 2011;125(3):175-8.
2011: Heinrich Lellek; Dirk Waldenmaier; Joachim Dahlke; Francis Ayuk; Christine Wolschke; Nicolaus Kröger; Axel R Zander
Caspofungin plus posaconazole as salvage therapy of invasive fungal infections in immunocompromised patients.
Mycoses 2011;54 Suppl 1():39-44.
2011: Nicolaus Kröger; Koichi Miyamura; Michael Bishop
Minimal residual disease following allogeneic hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(1 Suppl):S94-100.
2011: Evgeny Klyuchnikov; Ulrike Bacher; Nicolaus Kröger; Ilya Kazantsev; Tatjana Zabelina; Francis Ayuk; Axel Rolf Zander
The Role of Allogeneic Stem Cell Transplantation in Relapsed/Refractory Hodgkin's Lymphoma Patients.
Advances in hematology 2011;2011():974658.
2010: Bettina Wiedemann; Evgeny Klyuchnikov; Nicolaus Kröger; Tatjana Zabelina; Tanja Stahl; Silke Zeschke; A Badbaran; Francis Ayuk; Haefaa Alchalby; Christine Wolschke; Carsten Bokemeyer; Boris Fehse; Axel R Zander; Ulrike Bacher
Chimerism studies with quantitative real-time PCR in stem cell recipients with acute myeloid leukemia.
Experimental hematology 2010;38(12):1261-71.
2010: Ulrike Bacher; Torsten Haferlach; Tamara Alpermann; Melanie Zenger; Nicolaus Kröger; Dietrich W Beelen; Wolfgang Kern; Susanne Schnittger; Claudia Haferlach
Comparison of cytogenetic clonal evolution patterns following allogeneic hematopoietic transplantation versus conventional treatment in patients at relapse of AML.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(12):1649-57.
2010: Haefaa Alchalby; A Badbaran; Tatjana Zabelina; Guido Kobbe; Joachim Hahn; Daniel Wolff; Martin Bornhäuser; Christian Thiede; Herrad Baurmann; Wolfgang Bethge; York Hildebrandt; Ulrike Bacher; Boris Fehse; Axel R Zander; Nicolaus Kröger
Impact of JAK2V617F mutation status, allele burden, and clearance after allogeneic stem cell transplantation for myelofibrosis.
Blood 2010;116(18):3572-81.
2010: Nicolaus Kröger
Unrelated stem cell transplantation for patients with multiple myeloma.
Current opinion in hematology 2010;17(6):538-43.
2010: Henk M Lokhorst; Hermann Einsele; David Vesole; Benedetto Bruno; Jesus San Miguel; Jose A Pérez-Simon; Nicolaus Kröger; Philippe Moreau; Gosta Gahrton; Cristina Gasparetto; Sergio Giralt; William Bensinger
International Myeloma Working Group consensus statement regarding the current status of allogeneic stem-cell transplantation for multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(29):4521-30.
2010: Tanja Stahl; A Badbaran; Nicolaus Kröger; Evgeny Klyuchnikov; Tatjana Zabelina; Silke Zeschke; Philippe Schafhausen; Waltraud Schultz; Svetlana Asenova; Anna Smirnova; Christine Wolschke; Francis Ayuk; Axel R Zander; Boris Fehse; Ulrike Bacher
Minimal residual disease diagnostics in patients with acute myeloid leukemia in the post-transplant period: comparison of peripheral blood and bone marrow analysis.
Leukemia & lymphoma 2010;51(10):1837-43.
2010: Nicolaus Kröger; Ulrike Bacher; Peter Bader; Sebastian Böttcher; Michael J Borowitz; Peter Dreger; Issa Khouri; Eduardo Olavarria; Jerald Radich; Wendy Stock; Julie M Vose; Daniel Weisdorf; Andre Willasch; Sergio Giralt; Michael Bishop; ALAN WAYNE
NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on disease-specific methods and strategies for monitoring relapse following allogeneic stem cell transplantation. part II: chronic leukemias, myeloproliferative neoplasms, and lymphoid malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(10):1325-46.
2010: Caroline Pabst; Jozef Zustin; Frank Jacobsen; Tim Luetkens; Nicolaus Kröger; Georgia Schilling; Carsten Bokemeyer; Guido Sauter; Djordje Atanackovic; Andreas Marx
Expression and prognostic relevance of MAGE-C1/CT7 and MAGE-C2/CT10 in osteolytic lesions of patients with multiple myeloma.
Experimental and molecular pathology 2010;89(2):175-81.
2010: Yanran Cao; Tim Luetkens; Sebastian Kobold; York Hildebrandt; Maja Gordic; Nesrine Lajmi; Sabrina Meyer; Katrin Bartels; Axel R Zander; Carsten Bokemeyer; Nicolaus Kröger; Djordje Atanackovic
The cytokine/chemokine pattern in the bone marrow environment of multiple myeloma patients.
Experimental hematology 2010;38(10):860-7.
2010: Nicolaus Kröger; Ulrike Bacher; Peter Bader; Sebastian Böttcher; Michael J Borowitz; Peter Dreger; Issa Khouri; Homer A Macapinlac; Homer Macapintac; Eduardo Olavarria; Jerald Radich; Wendy Stock; Julie M Vose; Daniel Weisdorf; Andre Willasch; Sergio Giralt; Michael Bishop; ALAN WAYNE
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. Part I: Methods, acute leukemias, and myelodysplastic syndromes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(9):1187-211.
2010: H Alchalby; A Badbaran; O Bock; Boris Fehse; Ulrike Bacher; Axel R Zander; Nicolaus Kröger
Screening and monitoring of MPL W515L mutation with real-time PCR in patients with myelofibrosis undergoing allogeneic-SCT.
Bone marrow transplantation 2010;45(9):1404-7.
2010: Irene Cavattoni; Francis Ayuk; Axel R Zander; Tatjana Zabelina; Adelbert Bacher; Erdogan Cayroglu; Volker Knospe; Till Illies; Martin Aepfelbacher; Gisbert Richard; Nicolaus Kröger; Ulrike Bacher
Diagnosis of Toxoplasma gondii infection after allogeneic stem cell transplant can be difficult and requires intensive scrutiny.
Leukemia & lymphoma 2010;51(8):1530-5.
2010: Evgeny Klyuchnikov; Svetlana Asenova; Wolfgang Kern; Gökhan Kilinc; Francis Ayuk; Bettina Wiedemann; Michael V Lioznov; Petra Freiberger; Yuriy Zalyalov; Axel R Zander; Nicolaus Kröger; Ulrike Bacher
Post-transplant immune reconstitution after unrelated allogeneic stem cell transplant in patients with acute myeloid leukemia.
Leukemia & lymphoma 2010;51(8):1450-63.
2010: Nicolaus Kröger; Hermann Einsele; Günter Derigs; Hannes Wandt; Andreas Krüll; Axel Zander
Long-term follow-up of an intensified myeloablative conditioning regimen with in vivo T cell depletion followed by allografting in patients with advanced multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(6):861-4.
2010: Djordje Atanackovic; York Hildebrandt; Adam Jadczak; Yanran Cao; Tim Luetkens; Sabrina Meyer; Sebastian Kobold; Katrin Bartels; Caroline Pabst; Nesrine Lajmi; Maja Gordic; Tanja Stahl; Axel R Zander; Carsten Bokemeyer; Nicolaus Kröger
Cancer-testis antigens MAGE-C1/CT7 and MAGE-A3 promote the survival of multiple myeloma cells.
Haematologica 2010;95(5):785-93.
2010: Haefaa Alchalby; Nicolaus Kröger
Reduced-intensity conditioning followed by allogeneic hematopoietic stem cell transplantation in myelofibrosis.
Current hematologic malignancy reports 2010;5(2):53-61.
2010: Michael V Lioznov; J El-Cheikh; F Hoffmann; Y Hildebrandt; Francis Ayuk; Christine Wolschke; Djordje Atanackovic; Georgia Schilling; A Badbaran; Ulrike Bacher; Boris Fehse; Axel R Zander; D Blaise; M Mohty; Nicolaus Kröger
Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44(+)) and T (HLA-DR(+)) cells.
Bone marrow transplantation 2010;45(2):349-53.
2010: Nicolaus Kröger; Avichai Shimoni; Georgia Schilling; Rainer Schwerdtfeger; Martin Bornhäuser; Arnon Nagler; Axel R Zander; Marion Heinzelmann; Ronald Brand; Gösta Gahrton; Curly Morris; Dietger Niederwieser; Theo de Witte
Unrelated stem cell transplantation after reduced intensity conditioning for patients with multiple myeloma relapsing after autologous transplantation.
British journal of haematology 2010;148(2):323-31.
2010: Irene Cavattoni; Tatjana Zabelina; Francis Ayuk; Christine Wolschke; Ulrike Bacher; Axel Zander; Nicolaus Kröger
Pilot study of rituximab plus donor-lymphocyte infusion to prevent or treat relapse in B-cell lymphoma after allogeneic stem cell transplantation.
Leukemia & lymphoma 2010;51(1):146-8.
2009: Nicolaus Kröger; Ernst Holler; Guido Kobbe; Martin Bornhäuser; Rainer Schwerdtfeger; Herrad Baurmann; Arnon Nagler; Wolfgang Bethge; Matthias Stelljes; Lutz Uharek; Hannes Wandt; Andreas Burchert; Paolo Corradini; Jörg Schubert; Martin Kaufmann; Peter Dreger; Gerald G Wulf; Hermann Einsele; Tatjana Zabelina; Hans Michael Kvasnicka; Jürgen Thiele; Ronald Brand; Axel R Zander; Dietger Niederwieser; Theo M de Witte
Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Blood 2009;114(26):5264-70.
2009: Nicolaus Kröger; A Badbaran; Michael V Lioznov; Sabine Schwarz; Silke Zeschke; York Hildebrand; Francis Ayuk; Djordje Atanackovic; Georgia Schilling; Tatjana Zabelina; Ulrike Bacher; Evgeny Klyuchnikov; Avichai Shimoni; Arnon Nagler; Paolo Corradini; Boris Fehse; Axel Zander
Post-transplant immunotherapy with donor-lymphocyte infusion and novel agents to upgrade partial into complete and molecular remission in allografted patients with multiple myeloma.
Experimental hematology 2009;37(7):791-8.
2009: Francis Ayuk; Axel Zander; Nicolaus Kröger
Antitumor effects of polyclonal antithymocyte globulins: focus on B-cell malignancies and multiple myeloma.
Annals of hematology 2009;88(5):401-4.
2009: Francis Ayuk; Nadja Maywald; Sandra Hannemann; Ulrike Larsen; Axel Zander; Nicolaus Kröger
Comparison of the cytotoxicity of 4 preparations of anti-T-cell globulins in various hematological malignancies.
Anticancer research 2009;29(4):1355-60.
2009: Sunday Ocheni; Gabriela B Iwanski; Philippe Schafhausen; Axel R Zander; Francis Ayuk; Evgeny Klyuchnikov; Tatjana Zabelina; Walter Fiedler; Susanne Schnittger; Andreas Hochhaus; Tim H Brümmendorf; Nicolaus Kröger; Ulrike Bacher
Characterisation of extramedullary relapse in patients with chronic myeloid leukemia in advanced disease after allogeneic stem cell transplantation.
Leukemia & lymphoma 2009;50(4):551-8.
2009: Nicolaus Kröger; Tatjana Zabelina; Thomas Binder; Francis Ayuk; Ulrike Bacher; Gitta Amtsfeld; Heinrich Lellek; J Schrum; Rudolf Erttmann; Thomas Eiermann; Axel Zander
HLA-mismatched unrelated donors as an alternative graft source for allogeneic stem cell transplantation after antithymocyte globulin-containing conditioning regimen.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(4):454-62.
2009: Nicolaus Kröger; Ronald Brand; Anja van Biezen; Axel Zander; Judith Dierlamm; Dietger Niederwieser; Agnès Devergie; Tapani Ruutu; Jackie Cornish; Per Ljungman; Alois Gratwohl; Catherine Cordonnier; Dietrich W Beelen; Eric DECONINCK; Argiris Symeonidis; Theo de Witte
Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation.
Haematologica 2009;94(4):542-9.
2009: S Ocheni; Tatjana Zabelina; Ulrike Bacher; Francis Ayuk; Axel Zander; Nicolaus Kröger
Pegfilgrastim compared to lenograstim after allogeneic peripheral blood stem-cell transplantation from unrelated donors.
Leukemia & lymphoma 2009;50(4):612-8.
2009: Stefan O Schonland; Nicolaus Kröger; Christine Wolschke; Peter Dreger; Anthony D Ho; Ute Hegenbart
Donor lymphocyte infusions in amyloid light chain amyloidosis: induction of a "graft-versus-plasma cell-dyscrasia effect".
Haematologica 2009;94(3):439-41.
2009: Djordje Atanackovic; Tim Luetkens; York Hildebrandt; Julia Arfsten; Katrin Bartels; Christiane Horn; Tanja Stahl; Yanran Cao; Axel R Zander; Carsten Bokemeyer; Nicolaus Kröger
Longitudinal analysis and prognostic effect of cancer-testis antigen expression in multiple myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(4):1343-52.
2008: Uwe Platzbecker; Martin Bornhäuser; Ulrich Germing; Julian Stumpf; Bart L Scott; Nicolaus Kröger; Rainer Schwerdtfeger; Alexandra Böhm; Guido Kobbe; Catrin Theuser; Werner Rabitsch; Peter Valent; Mohamed L Sorror; Gerhard Ehninger; H Joachim Deeg
Red blood cell transfusion dependence and outcome after allogeneic peripheral blood stem cell transplantation in patients with de novo myelodysplastic syndrome (MDS).
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(11):1217-25.
2008: Jens Panse; K Friedrichs; A Marx; Y Hildebrandt; T Luetkens; K Barrels; C Horn; T Stahl; Y Cao; Karin Milde-Langosch; A Niendorf; Nicolaus Kröger; Sören Wenzel; Rudolf Leuwer; Carsten Bokemeyer; Susanna Hegewisch-Becker; Djordje Atanackovic
Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients.
British journal of cancer 2008;99(6):930-8.
2008: Stefan Kluge; Hans Jörg Baumann; Axel Nierhaus; Nicolaus Kröger; Andreas Meyer; Georg Kreymann
Safety of percutaneous dilational tracheostomy in hematopoietic stem cell transplantation recipients requiring long-term mechanical ventilation.
Journal of critical care 2008;23(3):394-8.
2008: Francis Ayuk; Jose A Perez-Simon; Avichai Shimoni; Anna Sureda; Tatjana Zabelina; Rainer Schwerdtfeger; Rodrigo Martino; Herbert G Sayer; Adrián Alegre; Juan José Lahuerta; Djordje Atanackovic; Christine Wolschke; Arnon Nagler; Axel R Zander; Jesús F San Miguel; Nicolaus Kröger
Clinical impact of human Jurkat T-cell-line-derived antithymocyte globulin in multiple myeloma patients undergoing allogeneic stem cell transplantation.
Haematologica 2008;93(9):1343-50.
2008: Francis Ayuk; Galina Diyachenko; Tatjana Zabelina; Christine Wolschke; Boris Fehse; Ulrike Bacher; Rudolf Erttmann; Nicolaus Kröger; Axel R Zander
Comparison of two doses of antithymocyte globulin in patients undergoing matched unrelated donor allogeneic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(8):913-9.
2008: Ulrike Bacher; Axel R Zander; Torsten Haferlach; Susanne Schnittger; Boris Fehse; Nicolaus Kröger
Minimal residual disease diagnostics in myeloid malignancies in the post transplant period.
Bone marrow transplantation 2008;42(3):145-57.
2008: Francis Ayuk; Galina Diyachenko; Tatjana Zabelina; Jens Panse; Christine Wolschke; Thomas Eiermann; Thomas Binder; Boris Fehse; Rudolf Erttmann; Hartmut Kabisch; Ulrike Bacher; Nicolaus Kröger; Axel R Zander
Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.
Experimental hematology 2008;36(8):1047-54.
2008: Francis Ayuk; Nabil Atassi; Gunther Schuch; Sormeh Mina; Lubin Fang; Carsten Bokemeyer; Boris Fehse; Axel R Zander; Nicolaus Kröger
Complement-dependent and complement-independent cytotoxicity of polyclonal antithymocyte globulins in chronic lymphocytic leukemia.
Leukemia research 2008;32(8):1200-6.
2008: Georgia Schilling; T Hansen; Avichai Shimoni; Tatjana Zabelina; J-A Pérez-Simón; J-A Simon-Perez; N C Gutierrez; W Bethge; P Liebisch; Rainer Schwerdtfeger; Martin Bornhäuser; S Otterstetter; E M M Penas; Judith Dierlamm; Francis Ayuk; Djordje Atanackovic; Ulrike Bacher; Carsten Bokemeyer; A Zander; J San Miguel; J S Miguel; Arnon Nagler; Nicolaus Kröger
Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma.
Leukemia 2008;22(6):1250-5.
2008: Axel R Zander; C Schmoor; Nicolaus Kröger; W Krüger; Volker Möbus; Norbert Frickhofen; Bernd Metzner; Wolfgang E Berdel; M Koenigsmann; E Thiel; Hannes Wandt; K Possinger; R Kreienberg; Martin Schumacher; W Jonat
Randomized trial of high-dose adjuvant chemotherapy with autologous hematopoietic stem-cell support versus standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: overall survival after 6 years of follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(6):1082-9.
2008: Nicolaus Kröger; R A Mesa
Choosing between stem cell therapy and drugs in myelofibrosis.
Leukemia 2008;22(3):474-86.
2007: Eray Goekkurt; Jan Stoehlmacher; Christian Stueber; Christine Wolschke; Thomas Eiermann; Simona Iacobelli; Axel R Zander; Gerhard Ehninger; Nicolaus Kröger
Pharmacogenetic analysis of liver toxicity after busulfan/cyclophosphamide-based allogeneic hematopoietic stem cell transplantation.
Anticancer research 2007;27(6C):4377-80.
2007: Nicolaus Kröger; Jürgen Thiele; Axel Zander; Rainer Schwerdtfeger; Guido Kobbe; Martin Bornhäuser; Wolfgang Bethge; Jörg Schubert; Theo de Witte; Hans Michael Kvasnicka
Rapid regression of bone marrow fibrosis after dose-reduced allogeneic stem cell transplantation in patients with primary myelofibrosis.
Experimental hematology 2007;35(11):1719-22.
2007: Theo de Witte; Stefan Suciu; Ronald Brand; Petra Muus; Nicolaus Kröger
Autologous stem cell transplantation in myelodysplastic syndromes.
Seminars in hematology 2007;44(4):274-7.
2007: Nicolaus Kröger
Mini-Midi-Maxi? How to harness the graft-versus-myeloma effect and target molecular remission after allogeneic stem cell transplantation.
Leukemia 2007;21(9):1851-8.
2007: Martin Kropff; Guido Bisping; Elke Schuck; Peter Liebisch; Nicola Lang; Marcus Hentrich; Tobias Dechow; Nicolaus Kröger; Hans Salwender; Bernd Metzner; Orhan Sezer; Monika Engelhardt; Hans-Heinrich Wolf; Hermann Einsele; Sarah Volpert; Achim Heinecke; Wolfgang E Berdel; Joachim Kienast
Bortezomib in combination with intermediate-dose dexamethasone and continuous low-dose oral cyclophosphamide for relapsed multiple myeloma.
British journal of haematology 2007;138(3):330-7.
2007: Ulrike Mösbauer; Francis Ayuk; Heike Schieder; Michael V Lioznov; Axel R Zander; Nicolaus Kröger
Monitoring serum free light chains in patients with multiple myeloma who achieved negative immunofixation after allogeneic stem cell transplantation.
Haematologica 2007;92(2):275-6.
2007: Djordje Atanackovic; Julia Arfsten; Yanran Cao; Sacha Gnjatic; Frank Schnieders; Katrin Bartels; Georgia Schilling; Christiane Faltz; Christine Wolschke; Judith Dierlamm; Gerd Ritter; Thomas Eiermann; Dieter K Hossfeld; Axel R Zander; Achim A Jungbluth; Lloyd J Old; Carsten Bokemeyer; Nicolaus Kröger
Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation.
Blood 2007;109(3):1103-12.
2006: Nicolaus Kröger; Thomas Binder; Tatjana Zabelina; Christine Wolschke; Heike Schieder; Helmut Renges; Francis Ayuk; Joachim Dahlke; Thomas Eiermann; Axel Zander
Low number of donor activating killer immunoglobulin-like receptors (KIR) genes but not KIR-ligand mismatch prevents relapse and improves disease-free survival in leukemia patients after in vivo T-cell depleted unrelated stem cell transplantation.
Transplantation 2006;82(8):1024-30.
2006: Nicolaus Kröger; Markus Frick; Oleg Gluz; Svjetlana Mohrmann; Bernd Metzner; Christian Jackisch; Yon Ko; Hans-Walter Lindemann; Carl Richard Meier; Hans Peter Lohrmann; Ute Ruffert; Mathias Hänel; Heinrich Bodenstein; Andreas Neubauer; Gerhard Ehninger; Hans-Heinrich Wolf; Kathrin Kolbe; Karin Burock; Axel R Zander; Ulrike Nitz
Randomized trial of single compared with tandem high-dose chemotherapy followed by autologous stem-cell transplantation in patients with chemotherapy-sensitive metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(24):3919-26.
2006: Niels W C J van de Donk; Nicolaus Kröger; Ute Hegenbart; Paolo Corradini; Jesús F San Miguel; Hartmut Goldschmidt; Jose A Perez-Simon; Maeike Zijlmans; Reinier A P Raymakers; Vittorio Montefusco; Francis Ayuk; Marinus H J van Oers; Arnon Nagler; Leo F Verdonck; Henk M Lokhorst
Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myeloma.
Bone marrow transplantation 2006;37(12):1135-41.
2006: Nicolaus Kröger; Tatjana Zabelina; Francis Ayuk; Djordje Atanackovic; Heike Schieder; Helmut Renges; Axel Zander
Bortezomib after dose-reduced allogeneic stem cell transplantation for multiple myeloma to enhance or maintain remission status.
Experimental hematology 2006;34(6):770-5.
2006: Nicolaus Kröger; Maria Zagrivnaja; Sabine Schwartz; Anita Badbaran; Tatjana Zabelina; Michael V Lioznov; Francis Ayuk; Axel Zander; Boris Fehse
Kinetics of plasma-cell chimerism after allogeneic stem cell transplantation by highly sensitive real-time PCR based on sequence polymorphism and its value to quantify minimal residual disease in patients with multiple myeloma.
Experimental hematology 2006;34(5):688-94.
2006: Niels W C J van de Donk; Nicolaus Kröger; Ute Hegenbart; Paolo Corradini; Jesús F San Miguel; Hartmut Goldschmidt; Jose A Perez-Simon; Maeike Zijlmans; Reinier A P Raymakers; Vittorio Montefusco; Francis Ayuk; Marinus H J van Oers; Arnon Nagler; Leo F Verdonck; Henk M Lokhorst
Remarkable activity of novel agents bortezomib and thalidomide in patients not responding to donor lymphocyte infusions following nonmyeloablative allogeneic stem cell transplantation in multiple myeloma.
Blood 2006;107(8):3415-6.
2006: Nicolaus Kröger; Avichai Shimoni; Tatjana Zabelina; Heike Schieder; Jens Panse; Francis Ayuk; Christine Wolschke; Helmut Renges; Joachim Dahlke; Djordje Atanackovic; Arnon Nagler; Axel Zander
Reduced-toxicity conditioning with treosulfan, fludarabine and ATG as preparative regimen for allogeneic stem cell transplantation (alloSCT) in elderly patients with secondary acute myeloid leukemia (sAML) or myelodysplastic syndrome (MDS).
Bone marrow transplantation 2006;37(4):339-44.
2006: Nicolaus Kröger; Karin Milde-Langosch; Sabine Riethdorf; Claudia Schmoor; Martin Schumacher; Axel R Zander; Thomas Löning
Prognostic and predictive effects of immunohistochemical factors in high-risk primary breast cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(1):159-68.
2006: Kai Gutensohn; MM Magens; William H Krüger; Nicolaus Kröger; Peter Kühnl
Comparison of flow cytometry vs. a haematology cell analyser-based method to guide the optimal time-point for peripheral blood stem cell apheresis.
Vox sanguinis 2006;90(1):53-8.
2006: Martin Bornhäuser; Nicolaus Kröger; Rainer Schwerdtfeger; Karin Schafer-Eckart; Herbert G Sayer; Christoph Scheid; Matthias Stelljes; Joachim Kienast; Peter Mundhenk; Stefan Fruehauf; Michael Kiehl; Hannes Wandt; Catrin Theuser; Gerhard Ehninger; Axel R Zander
Allogeneic haematopoietic cell transplantation for chronic myelogenous leukaemia in the era of imatinib: a retrospective multicentre study.
European journal of haematology 2006;76(1):9-17.
2006: Nicolaus Kröger; Ronald Brand; Anja van Biezen; J-Y Cahn; S Slavin; D Blaise; J Sierra; Axel Zander; Dietger Niederwieser; Theo de Witte
Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome.
Bone marrow transplantation 2006;37(2):183-9.
2006: Joachim Dahlke; Nicolaus Kröger; Tatjana Zabelina; Francis Ayuk; Natalja Fehse; Christine Wolschke; Olga Waschke; Heike Schieder; Helmut Renges; William H Krüger; A Kruell; Axel Hinke; Rudolf Erttmann; Hartmut Kabisch; Axel R Zander
Comparable results in patients with acute lymphoblastic leukemia after related and unrelated stem cell transplantation.
Bone marrow transplantation 2006;37(2):155-63.
2006: Anthony Oyekunle; Nicolaus Kröger; Tatjana Zabelina; Francis Ayuk; Heike Schieder; Helmut Renges; Natalja Fehse; Olga Waschke; Boris Fehse; Hartmut Kabisch; Axel R Zander
Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-up.
Bone marrow transplantation 2006;37(1):45-50.
2005: Francis Ayuk; Lubin Fang; Boris Fehse; Axel R Zander; Nicolaus Kröger
Antithymocyte globulin induces complement-dependent cell lysis and caspase-dependent apoptosis in myeloma cells.
Experimental hematology 2005;33(12):1531-6.
2005: Nicolaus Kröger; Bronwen Shaw; Simona Iacobelli; Tatjana Zabelina; Karl S Peggs; Avichai Shimoni; Arnon Nagler; Thomas Binder; Thomas Eiermann; Alejandro Madrigal; Rainer Schwerdtfeger; Michael Kiehl; Herbert G Sayer; Jörg Beyer; Martin Bornhäuser; Francis Ayuk; Axel R Zander; David I Marks
Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma.
British journal of haematology 2005;129(5):631-43.
2005: Johannes Schetelig; Astrid Breitschaft; Nicolaus Kröger; Tatjana Zabelina; Wolfram Ebell; Martin Bornhäuser; Astrid Haack; Gerhard Ehninger; Abdulgabar Salama; Wolfgang Siegert
After major ABO-mismatched allogeneic hematopoietic progenitor cell transplantation, erythroid engraftment occurs later in patients with donor blood group A than donor blood group B.
Transfusion 2005;45(5):779-87.
2005: Michael V Lioznov; P Freiberger; Nicolaus Kröger; Axel R Zander; Boris Fehse
Aldehyde dehydrogenase activity as a marker for the quality of hematopoietic stem cell transplants.
Bone marrow transplantation 2005;35(9):909-14.
2005: Nicolaus Kröger; Tatjana Zabelina; Heike Schieder; Jens Panse; Francis Ayuk; Norbert Stute; Natalja Fehse; Olga Waschke; Boris Fehse; Hans Michael Kvasnicka; Jürgen Thiele; Axel Zander
Pilot study of reduced-intensity conditioning followed by allogeneic stem cell transplantation from related and unrelated donors in patients with myelofibrosis.
British journal of haematology 2005;128(5):690-7.
2005: Gösta Gahrton; S Iacobelli; Jane Apperley; Giuseppe Bandini; Bo Björkstrand; J Bladé; Jean-Michel Boiron; Michele Cavo; J Cornelissen; P Corradini; Nicolaus Kröger; Per Ljungman; M Michallet; N H Russell; D Samson; A Schattenberg; Bhawna Sirohi; L F Verdonck; Liisa Volin; Axel Zander; Dietger Niederwieser
The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants.
Bone marrow transplantation 2005;35(6):609-17.
2005: Lubin Fang; Boris Fehse; Melanie Engel; Axel Zander; Nicolaus Kröger
Antithymocyte globulin induces ex vivo and in vivo depletion of myeloid and plasmacytoid dendritic cells.
Transplantation 2005;79(3):369-71.
2005: William H Krüger; Bettina Rüssmann; Maike de Wit; Nicolaus Kröger; Helmut Renges; Ingo Sobottka; Axel R Zander
Haemopoietic cell transplantation of patients with a history of deep or invasive fungal infection during prophylaxis with liposomal amphotericin B.
Acta haematologica 2005;113(2):104-8.
2005: Nicolaus Kröger; Ronald Brand; Anja van Biezen; D Bron; D Blaise; Eva Hellström-Lindberg; Gösta Gahrton; R Powles; T Littlewood; Bernard Chapuis; Axel Zander; V Koza; Dietger Niederwieser; Theo de Witte
Stem cell transplantation from identical twins in patients with myelodysplastic syndromes.
Bone marrow transplantation 2005;35(1):37-43.
2004: Holger Rohde; Matthias Kalitzky; Nicolaus Kröger; Stefanie Scherpe; Matthias A Horstkotte; Johannes K-M Knobloch; Axel R Zander; Dietrich Mack
Detection of virulence-associated genes not useful for discriminating between invasive and commensal Staphylococcus epidermidis strains from a bone marrow transplant unit.
Journal of clinical microbiology 2004;42(12):5614-9.
2004: Boris Fehse; Francis Ayuk; Nicolaus Kröger; Lubin Fang; Klaus Kühlcke; Marion Heinzelmann; Tatjana Zabelina; Axel A Fauser; Axel R Zander
Evidence for increased risk of secondary graft failure after in vivo depletion of suicide gene-modified T lymphocytes transplanted in conjunction with CD34+-enriched blood stem cells.
Blood 2004;104(10):3408-9.
2004: Nicolaus Kröger; Avichai Shimoni; Maria Zagrivnaja; Francis Ayuk; Michael V Lioznov; Heike Schieder; Helmut Renges; Boris Fehse; Tatjana Zabelina; Arnon Nagler; Axel R Zander
Low-dose thalidomide and donor lymphocyte infusion as adoptive immunotherapy after allogeneic stem cell transplantation in patients with multiple myeloma.
Blood 2004;104(10):3361-3.
2004: Nicolaus Kröger; Jose A Perez-Simon; Han Myint; Hans Klingemann; Avichai Shimoni; Arnon Nagler; Rodrigo Martino; Adrian Alegre; Jose F Tomas; Rainer Schwerdtfeger; Michael Kiehl; Axel A Fauser; Herbert G Sayer; Angel Leon; Jörg Beyer; Tatjana Zabelina; Francis Ayuk; Jesús F San Miguel; Ronald Brand; Axel R Zander
Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(10):698-708.
2004: Jean-Marie Tiercy; Jakob Passweg; Anja van Biezen; Axel Zander; Nicolaus Kröger; Alois Gratwohl; Bernard Chapuis; Claudine Helg; Lorentz Brinch; J Cornelissen; Machteld Oudshoorn; T Ruutu; Liisa Volin; Dietger Niederwieser; Eddy Roosnek
Isolated HLA-C mismatches in unrelated donor transplantation for CML.
Bone marrow transplantation 2004;34(3):249-55.
2004: Axel R Zander; Nicolaus Kröger; C Schmoor; William H Krüger; Volker Möbus; Norbert Frickhofen; Bernd Metzner; W Schultze; Wolfgang E Berdel; M Koenigsmann; E Thiel; Hannes Wandt; K Possinger; Lorenz Trümper; R Kreienberg; Marion Carstensen; E H Schmidt; Fritz Jänicke; M Schumacher; Walter Jonat
High-dose chemotherapy with autologous hematopoietic stem-cell support compared with standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: first results of a randomized trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(12):2273-83.
2004: Nicolaus Kröger; Georgia Schilling; Hermann Einsele; Peter Liebisch; Avichai Shimoni; Arnon Nagler; Jose A Perez-Simon; Jesús F San Miguel; Michael Kiehl; Axel A Fauser; Rainer Schwerdtfeger; Hannes Wandt; Herbert G Sayer; Han Myint; Hans Klingemann; Tatjana Zabelina; Judith Dierlamm; Axel Hinke; Axel R Zander
Deletion of chromosome band 13q14 as detected by fluorescence in situ hybridization is a prognostic factor in patients with multiple myeloma who are receiving allogeneic dose-reduced stem cell transplantation.
Blood 2004;103(11):4056-61.
2004: Johannes Schetelig; Martin Bornhäuser; Michael Kiehl; Rainer Schwerdtfeger; Nicolaus Kröger; Volker Runde; Tatjana Zabelina; Thomas K Held; Christian Thiede; Axel A Fauser; D Beelen; Axel Zander; Gerhard Ehninger; Wolfgang Siegert
Reduced-intensity conditioning with busulfan and fludarabine with or without antithymocyte globulin in HLA-identical sibling transplantation--a retrospective analysis.
Bone marrow transplantation 2004;33(5):483-90.
2004: Nicolaus Kröger; Stefan Sonnenberg; Lourdes Cortes-Dericks; Petra Freiberger; Hanke Mollnau; Axel R Zander
Kinetics of G-CSF and CD34+ cell mobilization after once or twice daily stimulation with rHu granulocyte-stimulating factor (lenograstim) in healthy volunteers: an intraindividual crossover study.
Transfusion 2004;44(1):104-10.
2003: Nicolaus Kröger; L Damon; Axel R Zander; Hannes Wandt; Günter Derigs; P Ferrante; Taner Demirer; G Rosti
Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients.
Bone marrow transplantation 2003;32(12):1153-7.
2003: Hermann Einsele; M Bamberg; W Budach; H Schmidberger; C F Hess; B Wörmann; Christoph Meisner; Christian Straka; Holger Hebart; Lorenz Trümper; Nicolaus Kröger; Axel R Zander; Susanna Hegewisch-Becker; D K Hossfeld; H Schmidt; P Müller; Günter Schlimok; Bernd Hertenstein; D Peest; Bernd Metzner; Norbert Frickhofen; Lothar Kanz; W I Bensinger
A new conditioning regimen involving total marrow irradiation, busulfan and cyclophosphamide followed by autologous PBSCT in patients with advanced multiple myeloma.
Bone marrow transplantation 2003;32(6):593-9.
2003: Axel R Zander; Nicolaus Kröger; Michael Schleuning; J Finke; Tatjana Zabelina; Dietrich W Beelen; Rainer Schwerdtfeger; H Baurmann; Martin Bornhäuser; Gerhard Ehninger; Axel A Fauser; Michael Kiehl; Rudolf Trenschel; Hellmut D Ottinger; H Bertz; J Berger; Hans-Jochem Kolb; Ulrich W Schaefer
ATG as part of the conditioning regimen reduces transplant-related mortality (TRM) and improves overall survival after unrelated stem cell transplantation in patients with chronic myelogenous leukemia (CML).
Bone marrow transplantation 2003;32(4):355-61.
2003: Nicolaus Kröger; Hermann Einsele; Daniel Wolff; Jochen Casper; Mathias Freund; Günter Derigs; Hannes Wandt; K Schäfer-Eckart; Georg Wittkowsky; Norbert Schmitz; William H Krüger; Tatjana Zabelina; Helmut Renges; Francis Ayuk; Andreas Krüll; Axel Zander
Myeloablative intensified conditioning regimen with in vivo T-cell depletion (ATG) followed by allografting in patients with advanced multiple myeloma. A phase I/II study of the German Study-group Multiple Myeloma (DSMM).
Bone marrow transplantation 2003;31(11):973-9.
2003: Nicolaus Kröger; Martin Bornhäuser; Gerhard Ehninger; Rainer Schwerdtfeger; H Biersack; Herbert G Sayer; Hannes Wandt; K Schäfer-Eckardt; Jörg Beyer; Michael Kiehl; Axel R Zander
Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
Annals of hematology 2003;82(6):336-42.
2003: M Weber; Nicolaus Kröger; Florian Langer; A Hansen; Tatjana Zabelina; Barbara Eifrig; Dieter K Hossfeld; Axel R Zander
Non-overt disseminated intravascular coagulation in patients during treatment with antithymocyte globulin for unrelated allogeneic hematopoietic stem cell transplantation.
Bone marrow transplantation 2003;31(9):817-22.
2003: Natalja Fehse; Boris Fehse; Nicolaus Kröger; Tatjana Zabelina; Petra Freiberger; William H Krüger; Hartmut Kabisch; Rudolf Erttmann; Axel R Zander
Influence of anti-thymocyte globulin as part of the conditioning regimen on immune reconstitution following matched related bone marrow transplantation.
Journal of hematotherapy & stem cell research 2003;12(2):237-42.
2003: Nicolaus Kröger; Axel R Zander; G Martinelli; P Ferrante; J M Moraleda; gian antonio da prada; Taner Demirer; Gerard Socie; G Rosti
Low incidence of secondary myelodysplasia and acute myeloid leukemia after high-dose chemotherapy as adjuvant therapy for breast cancer patients: a study by the Solid Tumors Working Party of the European Group for Blood and Marrow Transplantation.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(4):554-8.
2002: Florian Tögel; Nicolaus Kröger; F Korioth; Boris Fehse; Axel R Zander
Molecular methods for detection and quantification of myeloma cells after bone marrow transplantation: comparison between real-time quantitative and nested PCR.
Journal of hematotherapy & stem cell research 2002;11(6):971-6.
2002: Jörg Hessling; Nicolaus Kröger; Mathias Werner; Tatjana Zabelina; Arne Hansen; Uwe Kordes; Francis Ayuk; Helmut Renges; Jens Panse; Rudolf Erttmann; Axel R Zander
Dose-reduced conditioning regimen followed by allogeneic stem cell transplantation in patients with myelofibrosis with myeloid metaplasia.
British journal of haematology 2002;119(3):769-72.
2002: Nicolaus Kröger; Herbert G Sayer; Rainer Schwerdtfeger; Michael Kiehl; Arnon Nagler; Helmut Renges; Tatjana Zabelina; Boris Fehse; Francis Ayuk; Georg Wittkowsky; Norbert Schmitz; Axel R Zander
Unrelated stem cell transplantation in multiple myeloma after a reduced-intensity conditioning with pretransplantation antithymocyte globulin is highly effective with low transplantation-related mortality.
Blood 2002;100(12):3919-24.
2002: Nicolaus Kröger; Tatjana Zabelina; Helmut Renges; William H Krüger; Uwe Kordes; Johannes Rischewski; J Schrum; Martin Horstmann; Francis Ayuk; Rudolf Erttmann; Hartmut Kabisch; Axel R Zander
Long-term follow-up of allogeneic stem cell transplantation in patients with severe aplastic anemia after conditioning with cyclophosphamide plus antithymocyte globulin.
Annals of hematology 2002;81(11):627-31.
2002: Nicolaus Kröger; Rainer Schwerdtfeger; Michael Kiehl; Herbert G Sayer; Helmut Renges; Tatjana Zabelina; Boris Fehse; Florian Tögel; Georg Wittkowsky; Rolf Kuse; Axel R Zander
Autologous stem cell transplantation followed by a dose-reduced allograft induces high complete remission rate in multiple myeloma.
Blood 2002;100(3):755-60.
2002: Nicolaus Kröger; Axel R Zander
Dose and schedule effect of G-GSF for stem cell mobilization in healthy donors for allogeneic transplantation.
Leukemia & lymphoma 2002;43(7):1391-4.
2002: F Graf Finckenstein; Tatjana Zabelina; Matthias Dürken; Joachim Dahlke; Nicolaus Kröger; William H Krüger; Gritta E Janka-Schaub; Rudolf Erttmann; Axel R Zander; Hartmut Kabisch
[Unrelated donor stem cell transplantation in children: low toxicity using a GvHD-prophylaxis regimen with CSA, MTX, metronidazole,iv-immunoglobulin and ATG].
Klinische Pädiatrie 2002;214(4):206-11.
2002: Nicolaus Kröger; Tatjana Zabelina; Philippe Guardiola; Volker Runde; Jorge Sierra; Anja van Biezen; Dietger Niederwieser; Axel R Zander; Theo de Witte
Allogeneic stem cell transplantation of adult chronic myelomonocytic leukaemia. A report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
British journal of haematology 2002;118(1):67-73.
2002: Nicolaus Kröger; Helmut Renges; Stefan Sonnenberg; William H Krüger; Kai Gutensohn; T Dielschneider; Lourdes Cortes-Dericks; Axel R Zander
Stem cell mobilisation with 16 microg/kg vs 10 microg/kg of G-CSF for allogeneic transplantation in healthy donors.
Bone marrow transplantation 2002;29(9):727-30.
2002: Nicolaus Kröger; Tatjana Zabelina; William H Krüger; Helmut Renges; Norbert Stute; Johannes Rischewski; Stefan Sonnenberg; Francis Ayuk; Florian Tögel; UM Schade; Henning C Fiegel; Rudolf Erttmann; C Löliger; Axel R Zander
In vivo T cell depletion with pretransplant anti-thymocyte globulin reduces graft-versus-host disease without increasing relapse in good risk myeloid leukemia patients after stem cell transplantation from matched related donors.
Bone marrow transplantation 2002;29(8):683-9.
2002: P G C Begemann; HT Hassan; Nicolaus Kröger; William H Krüger; Hartmut Kabisch; Axel R Zander
Correlation of time to platelet engraftment with amount of transplanted CD34+CD41+ cells after allogeneic bone marrow transplantation.
Journal of hematotherapy & stem cell research 2002;11(2):321-6.
2002: Johannes Schetelig; Nicolaus Kröger; Thomas K Held; Christian Thiede; Andreas Krusch; Tatjana Zabelina; Marc Dubiel; Oliver Rick; Martin Bornhäuser; Gerhard Ehninger; Axel R Zander; Wolfgang Siegert
Allogeneic transplantation after reduced conditioning in high risk patients is complicated by a high incidence of acute and chronic graft-versus-host disease.
Haematologica 2002;87(3):299-305.
2002: Mathias Hänel; Nicolaus Kröger; Stefan Sonnenberg; Martin Bornhäuser; William H Krüger; Frank Kroschinsky; Annette Hänel; Bernd Metzner; Josef Birkmann; B Schmid; MM Hoffknecht; Friedrich Fiedler; Gerhard Ehninger; Axel R Zander
Busulfan, cyclophosphamide, and etoposide as high-dose conditioning regimen in patients with malignant lymphoma.
Annals of hematology 2002;81(2):96-102.
2002: Johannes Schetelig; Christian Thiede; Martin Bornhäuser; Rainer Schwerdtfeger; Michael Kiehl; Jörg Beyer; Nicolaus Kröger; M Hensel; christian scheffold; A D Ho; Joachim Kienast; Andreas Neubauer; Axel R Zander; Axel A Fauser; Gerhard Ehninger; Wolfgang Siegert
Reduced non-relapse mortality after reduced intensity conditioning in advanced chronic lymphocytic leukemia.
Annals of hematology 2002;81 Suppl 2():S47-8.
2001: William H Krüger; R J Hornung; B Hertenstein; W V Kern; Nicolaus Kröger; P Ljungman; Axel R Zander
Practices of infectious disease prevention and management during hematopoietic stem cell transplantation: a survey from the European group for blood and marrow transplantation.
Journal of hematotherapy & stem cell research 2001;10(6):895-903.
2001: Martin Bornhäuser; Michael Kiehl; Wolfgang Siegert; Johannes Schetelig; Bernd Hertenstein; H Martin; Rainer Schwerdtfeger; Herbert G Sayer; Volker Runde; Nicolaus Kröger; Catrin Theuser; Gerhard Ehninger
Dose-reduced conditioning for allografting in 44 patients with chronic myeloid leukaemia: a retrospective analysis.
British journal of haematology 2001;115(1):119-24.
2001: Nicolaus Kröger; Johannes Schetelig; Tatjana Zabelina; William H Krüger; Helmut Renges; Norbert Stute; J Schrum; Hartmut Kabisch; Wolfgang Siegert; Axel R Zander
A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome.
Bone marrow transplantation 2001;28(7):643-7.
2001: William H Krüger; Nicolaus Kröger; Florian Tögel; Helmut Renges; A Badbaran; R Hornung; R Jung; Kai Gutensohn; F Gieseking; Fritz Jänicke; Axel R Zander
Disseminated breast cancer cells prior to and after high-dose therapy.
Journal of hematotherapy & stem cell research 2001;10(5):681-9.
2001: Boris Fehse; A Chukhlovin; Klaus Kühlcke; O Marinetz; O Vorwig; Helmut Renges; William H Krüger; Tatjana Zabelina; O Dudina; F G Finckenstein; Nicolaus Kröger; Hartmut Kabisch; A Hochhaus; Axel R Zander
Real-time quantitative Y chromosome-specific PCR (QYCS-PCR) for monitoring hematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation.
Journal of hematotherapy & stem cell research 2001;10(3):419-25.
2001: Nicolaus Kröger; Tatjana Zabelina; William H Krüger; Helmut Renges; Norbert Stute; J Schrum; Hartmut Kabisch; Philippe Schafhausen; N Jaburg; C Löliger; P Schäfer; Axel Hinke; Axel R Zander
Patient cytomegalovirus seropositivity with or without reactivation is the most important prognostic factor for survival and treatment-related mortality in stem cell transplantation from unrelated donors using pretransplant in vivo T-cell depletion with anti-thymocyte globulin.
British journal of haematology 2001;113(4):1060-71.
2001: Nicolaus Kröger; Tatjana Zabelina; William H Krüger; Helmut Renges; Norbert Stute; Matthias Dürken; F Graf von Finkenstein; Rudolf Erttmann; Hartmut Kabisch; Philippe Schafhausen; N Jaburg; C Löliger; Axel R Zander
Anti-thymocyte-globulin as part of the preparative regimen prevents graft failure and severe graft versus host disease (GvHD) in allogeneic stem cell transplantation from unrelated donors.
Annals of hematology 2001;80(4):209-15.
2001: William H Krüger; Nicolaus Kröger; Florian Tögel; A Badbaran; Helmut Renges; F Gieseking; Kai Gutensohn; Fritz Jänicke; Axel R Zander
Influence of preharvest tumor cell contamination in bone marrow or blood does not predict resultant tumor cell contamination of granulocyte colony-stimulating factor mobilized stem cells.
Journal of hematotherapy & stem cell research 2001;10(2):303-7.
2001: Nicolaus Kröger; Tatjana Zabelina; William H Krüger; Helmut Renges; Norbert Stute; Hartmut Kabisch; N Jaburg; C Löliger; Andreas Krüll; Axel R Zander
Comparison of total body irradiation vs busulfan in combination with cyclophosphamide as conditioning for unrelated stem cell transplantation in CML patients.
Bone marrow transplantation 2001;27(4):349-54.
2001: Florian Tögel; C Datta; A Badbaran; Nicolaus Kröger; Helmut Renges; F Gieseking; Fritz Jänicke; Axel R Zander; William H Krüger
Urokinase-like plasminogen activator receptor expression on disseminated breast cancer cells.
Journal of hematotherapy & stem cell research 2001;10(1):141-5.
2001: Nicolaus Kröger; William H Krüger; Helmut Renges; Tatjana Zabelina; Norbert Stute; R Jung; Georg Wittkowsky; Rolf Kuse; Axel Zander
Donor lymphocyte infusion enhances remission status in patients with persistent disease after allografting for multiple myeloma.
British journal of haematology 2001;112(2):421-3.
2001: William H Krüger; R Jung; B Detlefsen; S Mumme; A Badbaran; J Brandner; Helmut Renges; Nicolaus Kröger; Axel R Zander
Interference of cytokeratin-20 and mammaglobin-reverse-transcriptase polymerase chain assays designed for the detection of disseminated cancer cells.
Medical oncology (Northwood, London, England) 2001;18(1):33-8.
2001: Mathias Hänel; Nicolaus Kröger; Frank Kroschinsky; Josef Birkmann; Annette Hänel; R Herbst; Ralph Naumann; K Friedrichsen; Gerhard Ehninger; Axel R Zander; Friedrich Fiedler
Salvage chemotherapy with mitoxantrone, fludarabine, cytarabine, and cisplatin (MIFAP) in relapsing and refractory lymphoma.
Journal of cancer research and clinical oncology 2001;127(6):387-95.
2000: W Krüger; C Datta; A Badbaran; Florian Tögel; Kai Gutensohn; I Carrero; Nicolaus Kröger; F Jänicke; Axel R Zander
Immunomagnetic tumor cell selection--implications for the detection of disseminated cancer cells.
Transfusion 2000;40(12):1489-93.
2000: Nicolaus Kröger; Helmut Renges; William H Krüger; Kai Gutensohn; C Löliger; I Carrero; L Cortes; Axel R Zander
A randomized comparison of once versus twice daily recombinant human granulocyte colony-stimulating factor (filgrastim) for stem cell mobilization in healthy donors for allogeneic transplantation.
British journal of haematology 2000;111(3):761-5.
2000: Nicolaus Kröger; MM Hoffknecht; William H Krüger; W Zeller; Helmut Renges; Norbert Stute; R Zschaber; Axel R Zander
Allogeneic bone marrow transplantation for refractory mantle cell lymphoma.
Annals of hematology 2000;79(10):578-80.
2000: Nicolaus Kröger; Tatjana Zabelina; Stefan Sonnenberg; William H Krüger; Helmut Renges; Norbert Stute; F Finkenstein; U Mayer; K Holstein; Walter Fiedler; H Colberg; Ruth Sonnen; Rolf Kuse; Dietrich Braumann; Bernd Metzner; F del Valle; Rudolf Erttmann; Hartmut Kabisch; Axel R Zander
Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia.
Bone marrow transplantation 2000;26(7):711-6.
2000: Mathias Hänel; Nicolaus Kröger; MM Hoffknecht; S O Peters; Bernd Metzner; Friedrich Fiedler; Dietrich Braumann; J C Schubert; Hans-Jochen Illiger; Annette Hänel; William H Krüger; W Zeller; HJ Weh; Dieter K Hossfeld; Axel R Zander
ASHAP--an effective salvage therapy for recurrent and refractory malignant lymphomas.
Annals of hematology 2000;79(6):304-11.
2000: Nicolaus Kröger; William H Krüger; Helmut Renges; W Zeller; C Rauhöft; C Löliger; Axel R Zander
Comparison of progenitor cell collection on day 4 or day 5 after steady-state stimulation with G-CSF alone in breast cancer patients: influence on CD34+ cell yield, subpopulation, and breast cancer cell contamination.
Journal of hematotherapy & stem cell research 2000;9(1):111-7.
2000: Peter Dreger; S Martin; Rolf Kuse; Ruth Sonnen; Bertram Glaß; Nicolaus Kröger; Reza Parwaresch; Michael Kneba; Norbert Schmitz; R Haas
The impact of autologous stem cell transplantation on the prognosis of mantle cell lymphoma: a joint analysis of two prospective studies with 46 patients.
The hematology journal : the official journal of the European Haematology Association / EHA 2000;1(2):87-94.
2000: Nicolaus Kröger; C Rauhöft; W Zeller; Helmut Renges; HT Hassan; William H Krüger; Gunter Schuch; G Wacker-Backhaus; H Colberg; Rolf Kuse; Kai Gutensohn; C Löliger; Axel R Zander
Efficacy of further attempts to mobilize CD34+ peripheral stem cells with alternative procedures after primary failure.
Acta haematologica 2000;102(3):144-7.
1999: W Zeller; Nicolaus Kröger; J Berger; William Krueger; Judith Dierlamm; Marcus Stockschläder; Kai Gutensohn; Dieter K Hossfeld; Axel R Zander
Expression of the adhesion molecules CD49d and CD49e on G-CSF-mobilized CD34+ cells of patients with solid tumors or non-Hodgkin's and Hodgkin's lymphoma and of healthy donors is inversely correlated with the amount of mobilized CD34+ cells.
Journal of hematotherapy & stem cell research 1999;8(5):539-46.
1999: Matthias Dürken; Martin Horstmann; P Bieling; Rudolf Erttmann; Hartmut Kabisch; C Löliger; E Marion Schneider; Hans-Henning Hellwege; William H Krüger; Nicolaus Kröger; Axel R Zander; Gritta Janka
Improved outcome in haemophagocytic lymphohistiocytosis after bone marrow transplantation from related and unrelated donors: a single-centre experience of 12 patients.
British journal of haematology 1999;106(4):1052-8.
1999: Axel R Zander; Tatjana Zabelina; Nicolaus Kröger; Helmut Renges; William H Krüger; C Löliger; Matthias Dürken; Marcus Stockschläder; Maike de Wit; G Wacker-Backhaus; Stefan S Bielack; N Jaburg; Bettina Rüssmann; Rudolf Erttmann; Hartmut Kabisch
Use of a five-agent GVHD prevention regimen in recipients of unrelated donor marrow.
Bone marrow transplantation 1999;23(9):889-93.
1999: William H Krüger; Florian Tögel; Nicolaus Kröger; S Rössing; F Gieseking; Kai Gutensohn; C Lindner; Fritz Jänicke; Axel R Zander
Tumour cell detection in G-CSF mobilised stem cell harvests of patients with breast cancer.
Medical oncology (Northwood, London, England) 1999;16(1):17-22.
1999: William H Krüger; Bettina Rüssmann; Nicolaus Kröger; C Salomon; N Ekopf; H A Elsner; Paul-Michael Kaulfers; D Mack; N Fuchs; Matthias Dürken; Hartmut Kabisch; Rudolf Erttmann; Axel R Zander
Early infections in patients undergoing bone marrow or blood stem cell transplantation--a 7 year single centre investigation of 409 cases.
Bone marrow transplantation 1999;23(6):589-97.
1999: William H Krüger; Florian Tögel; S Rössing; Nicolaus Kröger; Axel R Zander
Improvement of breast cancer cell detection by immunomagnetic enrichment.
Cytotherapy 1999;1(2):135-9.
1999: Nicolaus Kröger; W Zeller; HT Hassan; William H Krüger; Kai Gutensohn; C Löliger; Axel R Zander
Stem cell mobilization with G-CSF alone in breast cancer patients: higher progenitor cell yield by delivering divided doses (2 x 5 microg/kg) compared to a single dose (1 x 10 microg/kg).
Bone marrow transplantation 1999;23(2):125-9.
1998: William H Krüger; Nicolaus Kröger; Bettina Rüssmann; Helmut Renges; Hartmut Kabisch; Axel R Zander
Treatment of mycotic infections after haemopoietic progenitor cell transplantation with liposomal amphotericin-B.
Bone marrow transplantation 1998;22 Suppl 4():S10-3.
1998: Nicolaus Kröger; William H Krüger; G Wacker-Backhaus; Susanna Hegewisch-Becker; Marcus Stockschläder; N Fuchs; Bettina Rüssmann; Helmut Renges; Matthias Dürken; Stefan S Bielack; Maike de Wit; Gunter Schuch; H Bartels; Dietrich Braumann; Rolf Kuse; Hartmut Kabisch; Rudolf Erttmann; Axel R Zander
Intensified conditioning regimen in bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia.
Bone marrow transplantation 1998;22(11):1029-33.
1998: Nicolaus Kröger; W Zeller; Natalja Fehse; HT Hassan; William H Krüger; Kai Gutensohn; C Lölliger; Axel R Zander
Mobilizing peripheral blood stem cells with high-dose G-CSF alone is as effective as with Dexa-BEAM plus G-CSF in lymphoma patients.
British journal of haematology 1998;102(4):1101-6.
1998: Nicolaus Kröger; W Zeller; HT Hassan; William H Krüger; Helmut Renges; K Hummel; Kai Gutensohn; C Lölliger; Axel R Zander
Successful mobilization of peripheral blood stem cells in heavily pretreated myeloma patients with G-CSF alone.
Annals of hematology 1998;76(6):257-62.
1998: Nicolaus Kröger; MM Hoffknecht; Mathias Hänel; William H Krüger; W Zeller; Marcus Stockschläder; Maike de Wit; HJ Weh; Hartmut Kabisch; Rudolf Erttmann; Axel R Zander
Busulfan, cyclophosphamide and etoposide as high-dose conditioning therapy in patients with malignant lymphoma and prior dose-limiting radiation therapy.
Bone marrow transplantation 1998;21(12):1171-5.
1998: Marc-Alexander burmeister; Thomas Standl; P Brauer; K Ramsperger; Nicolaus Kröger; Axel Zander; Jochen Schulte am Esch
Safety and efficacy of spinal vs general anaesthesia in bone marrow harvesting.
Bone marrow transplantation 1998;21(11):1145-8.
1998: William H Krüger; M Gruber; S Hennings; Natalja Fehse; Boris Fehse; Kai Gutensohn; Nicolaus Kröger; Axel R Zander
Purging and haemopoietic progenitor cell selection by CD34+ cell separation.
Bone marrow transplantation 1998;21(7):665-71.
1998: Nicolaus Kröger; W Zeller; HT Hassan; W Krüger; C Löliger; Axel R Zander
Schedule-dependency of granulocyte colony-stimulating factor in peripheral blood progenitor cell mobilization in breast cancer patients.
Blood 1998;91(5):1828.
1998: Nicolaus Kröger; MM Hoffknecht; P Dreger; William H Krüger; W Zeller; Andreas Krüll; Marcus Stockschläder; S Bittner; HJ Weh; Axel R Zander
Long-term disease-free survival of patients with advanced mantle-cell lymphoma following high-dose chemotherapy.
Bone marrow transplantation 1998;21(1):55-7.
1998: Nicolaus Kröger; W Zeller; HT Hassan; Judith Dierlamm; Axel R Zander
Difference between expression of adhesion molecules on CD34+ cells from bone marrow and G-CSF-stimulated peripheral blood.
Stem cells (Dayton, Ohio) 1998;16(1):49-53.
1997: Axel R Zander; C Berger; Nicolaus Kröger; M Stockshläder; William H Krüger; Martin Horstmann; Jan Grimm; W Zeller; Hartmut Kabisch; Rudolf Erttmann; P Schönrock; Rolf Kuse; Dietrich Braumann; Hans-Jochen Illiger; Walter Fiedler; M de Witt; K D Hossfeld; HJ Weh
High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(12 Pt 2):2671-5.
1997: Marcus Stockschläder; HT Hassan; W Zeller; William H Krüger; J Clausen; C Löliger; A T Dieck; Nicolaus Kröger; H Link; H Kabisch; D K Hossfeld; A Zander
Allogeneic transplantation with CD34+-selected cells.
Leukemia & lymphoma 1997;25(1-2):145-51.
1997: William H Krüger; Marcus Stockschläder; Ingo Sobottka; R Betker; Maike de Wit; Nicolaus Kröger; Jan Grimm; M Arland; Walter Fiedler; Rudolf Erttmann; Axel R Zander
Antimycotic therapy with liposomal amphotericin-B for patients undergoing bone marrow or peripheral blood stem cell transplantation.
Leukemia & lymphoma 1997;24(5-6):491-9.
1996: Axel R Zander; W Krüger; Nicolaus Kröger; L Damon; M Königmann; W E Berdel; F Gieseking; K Schäfer-Eckart; V Möbus; N Frickhofen; Hannes Wandt; Hans-Jochen Illiger; Bernd Metzner; K Kolbe; B Wörmann; L Trümper; C Huber; Dieter K Hossfeld; H Maass; W Jonat
High dose mitoxantrone with thiotepa, cyclophosphamide and autologous stem cell rescue for high risk stage II and stage III breast cancer. German GABG-4/EH-93-Study.
Bone marrow transplantation 1996;18 Suppl 1():S24-5.
1996: Judith Dierlamm; L Michaux; Nicolaus Kröger; Iwona Wlodarska; Philippe Martiat; W Zeller; D Seeger; Cristina Mecucci; Herman Van Den Berghe; D K Hossfeld
ider(9)(q10)t(9;22)(q34;q11) is a recurrent chromosomal abnormality in acute lymphoblastic leukemia and lymphatic blastic phase of chronic myelogenous leukemia.
Cancer genetics and cytogenetics 1996;89(2):109-13.
1996: W Zeller; Kai Gutensohn; Marcus Stockschläder; Judith Dierlamm; Nicolaus Kröger; Guenther Koehne; K Hummel; Hartmut Kabisch; HJ Weh; P Kühnl; D K Hossfeld; Axel R Zander
Increase of mobilized CD34-positive peripheral blood progenitor cells in patients with Hodgkin's disease, non-Hodgkin's lymphoma, and cancer of the testis.
Bone marrow transplantation 1996;17(5):709-13.
1996: W Krüger; C Krzizanowski; M Holweg; Marcus Stockschläder; Nicolaus Kröger; R Jung; K Mross; W Jonat; Axel R Zander
Reverse transcriptase/polymerase chain reaction detection of cytokeratin-19 mRNA in bone marrow and blood of breast cancer patients.
Journal of cancer research and clinical oncology 1996;122(11):679-86.
1995: W Krüger; Marcus Stockschläder; Bettina Rüssmann; C Berger; MM Hoffknecht; I Sobottka; B Kohlschütter; G Kroschke; Nicolaus Kröger; Martin Horstmann
Experience with liposomal Amphotericin-B in 60 patients undergoing high-dose therapy and bone marrow or peripheral blood stem cell transplantation.
British journal of haematology 1995;91(3):684-90.
1995: B Thürlimann; Nicolaus Kröger; J Greiner; K Mross; J Schüller; E Schernhammer; K Schumacher; G Gastl; J Hartlapp; H Kupper
Dexverapamil to overcome epirubicin resistance in advanced breast cancer.
Journal of cancer research and clinical oncology 1995;121 Suppl 3():R3-6.